Star Chain, a cryptocurrency concept stock, announced it will suspend trading on the Hong Kong Stock Exchange starting November 26, following concerns over its ability to meet continuous listing requirements. The announcement led to a 73% drop in its stock price on November 17. The exchange cited Star Chain's failure to maintain sufficient operational levels and lack of substantial assets as reasons for the suspension under Listing Rule 13.24.
Formerly known as Leading Pharma Biotech, Star Chain rebranded in September 2025. In October, the company signed a memorandum with Starcoin Foundation to issue Starcoin tokens, planned for deployment on Conflux eSpace. Notably, Conflux founders Long Fan and Wu Ming previously served as executive directors at Leading Pharma.
Crypto Stock Star Chain to Suspend Trading Amid Listing Concerns
Disclaimer: The content provided on Phemex News is for informational purposes only. We do not guarantee the quality, accuracy, or completeness of the information sourced from third-party articles. The content on this page does not constitute financial or investment advice. We strongly encourage you to conduct you own research and consult with a qualified financial advisor before making any investment decisions.
